As a proof of principle, HIPK2 silencing with small interfering RNA upregulated HIF-1α in cancer cells, inducing a pseudohypoxic tumor phenotype in normoxic conditions, fueling tumor progression, and chemoresistance [28]. Here, HIPK2 is linked to neoplasm.